干扰素治疗慢性病毒性肝炎诱发甲状腺功能障碍2例报告
Interferon induced thyroid dysfunction in patients with chronic hepatitis(with 2 cases and review of literatures)
出处
《中国热带医学》
CAS
2003年第2期192-193,共2页
China Tropical Medicine
参考文献13
-
1[1]Oberg k,Norheim Ⅰ ,Lind E,et al.treatment of malignant carcinoid tumors with human leukocyte Interferon: ong-term results. Cancer Treat Rep 1986Nov, 70( 11 ): 1297 ~ 1304.
-
2[2]Sauter NP, Atkins MB, Mier JW, et al. Transient thyrotoicosis and persistent hypothyroidism due to acute autoinmune thyroiditis after interleukin - 2 and interferon-alpha therapy metastatic carcinoma: a case report. Am J Med 1992Apr,92(4) :441 ~ 444.
-
3[3]Katabami S, Kami Jo K, Kodama T et al. An episode of silent thyroiditis in a patient with chronic thyroiditis and papillary adenocarcinoma following alpha interferon treatment for hepatitis C.Endocr J 1993 Jun 40(3) :311 ~ 316.
-
4[4]Carella C, Amato G, Biondi B, et al. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res 1995,44(3):110 ~ 114.
-
5[5]Carella C, Mazziotti G, Morisco F,et al. Long-term outcome of interferon-alpha-induced thyroid outoimmunify and prognostic influence of thyroid autoantibody patterm at the end of treatment. J Clin Endocrinol Metab 2001May,86(5): 1925 ~ 1929.
-
6[6]Selzer E,Wilfing A,Sexl V,et al. Effects of type Ⅰ - interferons on human thyroid epithelial cells derived frou normal and tuuour tissue. Naunyn Schmiedebergs Arch pharmacol. 1994 Sep,350(3)322 ~ 328.
-
7[7]Wang V, Fu AX, George J, et al. Thyroto cosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin Endocrinol (oxf), 2002 Jun, 56 (6):793 ~ 798.
-
8[8]Ghilardi G, Gonvers JJ,So A. Hypothyroid myopathy as a complication of interferon. Br J Rheumatol 1998 Dec,37(12): 1349 ~ 1351.
-
9[9]Fermandez-Soto L, Gonzalez A, Escobar-Jinenez F, et al. Increased risk of autoimmune thyroid disease in hepatitis Cvs hepatitis B before, during and after discontnuing interferon therapy. Arch Intem Med 1998 Jul 13,158(13): 1445 ~ 1448.
-
10[10]Romagnani P, Rotondi M,Lazzeri E,et al. Expression ofIP- 10/CXCL 10 and MIG/CCL9 in the thyroid and increased levels of IP- 10/CXCL10 in the serum of patients with recent-onset Graves Disase. Am J pathol 2002 Ju,161(1) :195 ~ 206.
-
1彭静,刘煜,曹真真.亚临床甲状腺功能减退症对糖尿病血管并发症的影响[J].国际内分泌代谢杂志,2017,37(1):23-26. 被引量:4
-
2易宣孜,戴丽芬,金醒昉.丙型肝炎患者干扰素治疗后由亚临床甲减转为甲亢的1例报道[J].重庆医学,2017,46(11):1581-1582. 被引量:1
-
3杨莹莹.糖尿病患者合并甲状腺功能障碍的临床分析[J].中国药业,2012,21(A02):257-257.
-
4李双一.药物引起甲状腺功能障碍[J].药物流行病学杂志,1996,5(4):214-216. 被引量:1
-
5周学灵.糖尿病患者合并甲状腺功能障碍46例分析[J].中国医药指南,2013,11(24):217-218. 被引量:4
-
6杨云花.糖尿病患者合并甲状腺功能障碍90例体会[J].中国农村卫生,2015,7(1X):87-88. 被引量:1
-
7杨安军,高雪燕.胺碘酮联合美托洛尔控制快速心房颤动伴充血性心力衰竭的安全性观察[J].中国社区医师(医学专业),2009,11(12):26-26. 被引量:6
-
8鲁俊峰.丙型肝炎病毒的治疗在男性中可引起甲状腺功能障碍[J].传染病网络动态,2005(2):7-7.
-
9范文,陈峻,吴沙沙.原发性高血压患者血清Hcy、hs-CRP和FA检测的临床意义[J].放射免疫学杂志,2013,26(2):225-225. 被引量:3
-
10崇巍,孙炜,滕卫平.碘摄入量与甲状腺功能障碍关系的多因素分析(英文)[J].中国现代医学杂志,2005,15(9):1285-1288. 被引量:7